1/68
Looks like no tags are added yet.
pt is at low risk for TLS. What should you treat them with?
hydration
uric acid: consider allopurinol if indicated based on malignancy/treatment risk
risk-based monitoring: baseline and periodic TLS monitoring
pt is at intermediate risk for TLS. What should you treat them with?
IV hyration as tolerated
frequent labs
uric acid: allopurinol or alt XO inhibitor
assess outpatient vs inpatient monitoring
pt is at high risk for TLS. What should you treat them with?
IV hydration as tolerated w fluid balance and urine output assessment
close labs/ consider telemetry
rasburicase if appropriate; assess G6PD status
assess inpatient monitoring
pt has established TLS What should you treat them with?
immediate care: urgent correction of abnormalities
individualized isotonic IV fluids
frequent labs, ECG, and urine output
rasburicase if appropriate, monitor response
escalation: intensive monitoring, nephrology/dialysis if indicated
What should you monitor for patients at risk for TLS before starting therapy?
baseline K, Phos, Ca, uric acid, Cr, LDH and volume status
What should you monitor for patients at risk for TLS during risk period?
repeat electrolytes, uric acid, kidney function based on risk, therapy and thrends
monitor urine output and fluid balance
When should you escalate monitoring in pts at risk for TLS?
increase freq w laboratory changes, oliguria, arrhythmia risk or established TLS
When should you consider inpatient observation/telemetry for pts at risk for TLS?
pt is high risk or clinically unstable; use therapy-specific monitoring schedules
Describe hydration for TLS management. What is the target urine output?
isotonic IV crystalloids; individualize fluids to volume status, cardiac function and renal function
target: 2mL/kg/hr
avoid nephrotoxins!!
Loop diuretics are not routinely recommended for TLS prophylaxis and do NOT reaplce adequate hydration. When is it considered?
when pt has fluid overload after assesssing volume status
When should nephrology/renal reaplacement therapy be initiated for TLS therapy?
pt has refractory hyperkalemia, severe or worsening hyperphosphatemia, or symptomatic hypocalcemia with hyperphosphatemia
for fluid overload or severe AKI; dialysis isn’t required for every pt
What is the management strategy for potassium in TLS?
frequent monitoring + ECG monitoring of calcium gluconate
avoid IV and oral K
Sodium polystyrene sulfonate
Sodium zirconium cyclosilicate
Regular IV insulin/D50W
Albuterol
Sodium bicarbonate
Loop diuretics
Dialysis
What is the management strategy for phosphate in TLS?
Avoid IV phosphate administration
Phosphate binders (Sevelamer)
Dialysis
What is the management strategy for calcium in TLS?
If symptomatic, calcium gluconate IV administered slowly with ECG monitoring
What are the manifestations of hyperkalemia?
serum K >5 mEq/L
earliest EKG change: peaked T waves
often asymptomatic; may experience palpitations

What is consider mild, moderate and severe hyperkalemia?
Mild: 5-5.9 mEq/L
Moderate: 6-6.9 mEq/L
Severe hyperkalemia: ≥7 mEq/L
What is the general approach for acute moderate to severe hyperkalemia? (>6 mEq/L)
immediate treatment with an agent that lowers K to <5 mEq/L quickly as EKG changes may start to occur at 5.5-6mEq/L
pt has moderate to severe hyperkalemia (>6 mEq/L), how should you treat them?
obtain EKG: if changes are present, stabilize cardiac membrane with Ca2+, then give agents to lower K quickly. If no changes then proceed with K lowering agents.
admin agents to lower K quickly: IV regular insulin
First line agent to lower K quickly
IV regualr insulin
How can you stabilize the cardiac cell membrane?
calcium gluconate 1-3g IV/IM
OR calcium chloride 1 g IV
What is the MOA of calcium?
raises cardiac membrane potential and stabilize myocardium (onset 1-2min) HAS NO EFFECT ON SERUM K
Which calcium agent is more preferred and why?
calcium gluconate is preferred bc calcium chloride can cause extravasation and tissue necrosis
Potassium shifters shift potassium intracellularly by stimulating the Na/K ATPase pump. What is the first line agent for this?
IV insulin regular (humulin R/Novolin R) ± dextrose
how much IV insulin should you give when pt has renal insufficiency vs they don’t have renal insufficiency?
no renal insuff: 10 units
has renal insuff: 5 units
When administering IV insulin regular ± dextrose, when should you omit the dextrose component?
glucose >250g/dL
What are additional potassium shifter agents that may be considered for hyperkalemia?
nebulized albuterol 10-20mg over 10 min
sodium bicarb 50mEq IV
When should you consider sodium bicarbonate 50mEq IV in TLS hyperkalemia?
in pts with concurrent metabolic acidosis (controversial)
TLS pt has mild hyperkalemia without any symptoms or EKG changes. What can you give them?
SPS(Kayexalate)
SZC (Lokelma)
Furosemide
Dialysis
What are the clinical pearls about SPS (Kayexalate)?
MOA: cation exchange resin that binds K+ in intestines and excreted in the feces
15-30g PO OR 30-50g rectal enema
hours to days effect
formulated w sorbitol to dec constipation → GI necrosis
What are the clinical pearls of SZC (Lokelma)?
moa: cation exchange resin that binds to K+ in the intesintes and excreted via feces
dose: 10g PO TID for up to 48rs
onset: 1hr
peak fx at 2 hr
lower rate of GI fx compared to SPS
What are the clinical pearls about furosemide (Lasix)?
moa: loop diuretic that inhib reabsorpt of sodium and chloride in ascending loop of henle and prox and distal renal tubules
dose: 40-80mg IV
onset: 5-30min
adjunctive therapy for pts who are fluid overloaded
What are the manifestations of hyperphosphatemia
serum phosphate >4.5 mg/dL
GI upset: N/V/D
Neurologic: altered mental status, lethargy, seizures
Ca-PO4 precipitate can exacerbate renal failure
What is the treatment for hyperphosphatemia? What is the MOA?
phosphate binder
moa: reduces absorption of dietary phosphate in GI tract, by exchanging anion phosphate with an active cation to form a nonabsorbable compound that gets excreted in the feces
What are examples of phosphate binders?
sevelamer carbonate (renvela)
calcium carbonate (tums) or calcium acetate (phoslo)
aluminum hydroxide
What are the clinical pearls of sevelamer carbonate (Renvela)?
Dose by phosphate level:
>5.5 to <7.5 mg/dL: 800 mg TID with meals
7.5 to <9 mg/dL: 1,200 to 1,600 mg TID with meals
≥9 mg/dL: 1,600 mg TID with meals
Dosing not studied in TLS -> extrapolated from CKD dosing
What are the clinical pearls of calcium carbonate and calcium acetate?
Dose: 500 - 1000 mg of elemental calcium PO TID with meals
Carbonate = 40% elemental calcium, acetate = 25% calcium
Can bind with phosphate and potentially precipitate renal failure
What are the clinical pearls of aluminum hydroxide?
Dose: 300 - 600 mg PO TID with meals
Limit duration due to risk for aluminum toxicity (encephalopathy, osteomalacia, microcytic anemia)
What should you give to treat hyperuricemia?
allopurinol
rasburicase
sodium bicarbonate

which hyperuricemia agent prevents conversion of xanthine and hypoxanthine to uric acid? (MOA: inhibits xanthine oxidase, preventing conversion of xanthine and hypoxanthine uric acid) and what is the dose?
allopurinol
PO: 300mg/m²/d OR 10mg/kg/d divided every 8 hrs (max 800mg); typical dose 300mg QD or BID
IV: 200-400mg/m²/d in 1-3 divided doses
What are the ADE of allopurinol?
n/d
increased LFTs
hypersensitivity (SJS, toxic epidermal necrolysis)
What are the limitations of allopurinol?
ineffective at reducing levels of uric acid already developed
Leads to buildup of xanthine and hypoxanthine metabolites → Xanthine nephropathy
DDI: Decreases clearance of purine analogs (6- mercaptopurine, azathioprine)
which hyperuricemia agent is a recombinant urate oxidase that converts uric acid to allantoin and decreases serum uric acid levels within 4 hrs?
rasburicase
Manufacturer’s labeling: 0.2 mg/kg IV daily for up to 5 days
What is the fixed dosing approach for rasburicase?
3-7.5mg as a single dose based on serum uric acid levels
What are the CI of rasburicase(elitek)
Hypersens
ho hemolytic rxn or methemoglobinemia w rasburicase
Glucose-6-phosphate dehydrogenase (G6PD) def
What are the BBW of rasburicase?
Hypersensitivity reactions
Methemoglobinemia
Hemolysis in G6PD deficiency
Interference with uric acid measurements
What BBW of rasburicase requires screening before initiation?
Hemolysis in G6PD deficiency: Screen patients at high risk (African or Mediterranean ancestry) prior to starting rasburicase
which hyperuricemia agent inc solubility of uric acid, dec solubility of calcium phosphate. It also may lead to metabolic alkalosis and is NOT routinely utilized to manage hyperuricemia
sodium bicarbonate
Febuxostate (Uloric) is a xanthine oxidease inhibitor FDA approved to treat hyperuricemia. What is the florence trial?
mean seruc uric acid was significantly lower in febuxostate group (pts with hematologic malignancies at intermediate to high risk TLS)
What are the ADE of febuxostat? CI?
ADE: LFT abnormal, n, arthralgia, rash, severe skin rxns (SJS, DRESS, TEN)
CI: concurrent use of azathioprine or mercaptopurine
What is the BBW of febuxostat?
Gout patients with established cardiovascular disease treated with febuxostat had a higher rate of CV death compared to those treated with allopurinol in a CV outcomes study
What is TLS?
oncologic emergency: rapid large-scale destruction of malignant cells releases IC contents faster than the body can clear them
occurs within days of starting chemo
When is TLS common?
hematologic malignancies (acute leukemias, aggressive lymphomas), but also reported after radiation, intrathecal chemo and in solid tumors
venetoclax, CAR T cells, bispecific ABX cause TLS in low risk diseases
T/F early recognition of TLS and prevention of TLS reduces kidney injury and death
true
What are the disease (tumor) factors of TLS?
Histology: Burkitt, lymphoblastic lymphoma, ALL, AML, aggressive (high-grade) lymphoma
High tumor burden: bulky mass >10 cm, WBC ≥100 × 10⁹/L, advanced stage
LDH > upper limit of normal (ULN), especially ≥2× ULN
High proliferation rate (e.g., high Ki-67)
Bone marrow or organ (incl. renal) inflammation
What are the patient risk factors of TLS?
Pre-existing kidney dysfunction or renal involvement
Dehydra, volume deple, HoT
Pre-existing hyperuric, hyperphos or hyperkal
NSAIDs, ACEi/ARB, SGLT2i, metformin, K⁺-sparing diuretics
Frailty; unable to maintain oral fluid intake
Look at this chart (TLS risk by disease)

SEQ pathophysiology of TLS
DNA → purines → hypoxanthina → xanthine → uric acid by XO
malignant cells: 4x phosphate lvls
potassium: released directly into plasma
cytokines: cause HoT and inflamm → kidney injury
AKI AND TLS IS A CYCLE
Why does the kidney fail?
uric acid nephropathy
calcium phosphate deposition
xanthine nephropathy
describe uric acid nephropathy
uric acid pKa = 5.4
crystals obstruct tubules
crystal independent injury: renal vascons, impaired autoreg, oxidative stress, inflamm
describe calcium phosphate deposition
high phosphate binds calcium
precipitates in tubules and tissues (nephrocalcinosis)
risk rises sharlply when Ca x PO4 product >= 60 mg²/dL²
leads to secondary hypocalcemia
describe xanthine nephropathy
xanthine is less soluble than uric acid
accum when XO is blocked (allopurinol, febuxostat)
not measure routinely, suspect if kidney function worsens on therapy
which clinical manifestation is this: Cardiac arrhythmias (peaked T waves, widened QRS, VT/VF, cardiac arrest); muscle weakness, cramps, paresthesias
hyperkalemia
which clinical manifestation is this: Nausea, vomiting, diarrhea, lethargy, seizures; Ca- PO₄ precipitation worsens AKI
hyperphosphatemia
which clinical manifestation is this: Tetany, cramps, paresthesias, Chvostek/Trousseau signs, prolonged QT, arrhythmias, hypotension, seizures
hypocalcemia (secondary)
which clinical manifestation is this:Usually silent until AKI: oliguria/anuria, flank pain, hematuria; fluid overload, edema
hyperuricemia
which clinical manifestation is this: Worsens every abnormality above by reducing clearance (vicious cycle
acute kidney injury
What is considered laboratory TLS? (Cairo bishop criteria)
uric acid: >= 8mg/dL
potassium: >=6 mEq/L
phosphate: >= 4.5 mg/dL adults
calcium: =<7 mg/dL
>=2 of these within the same 24 hrs
What is considered clinical TLS? (cairo bishop criteria)
laboratory TLS PLUS
one or more of the following:
creatinine: >=1.5 x ULN
cardiac arrhythmia
seizure
sudden death
what are the refinements of clinical TLS
any symptomatic hypocalcemia counts as clinical TLS
kidney criterion as AKI: Cr rise >0.3mg/dL, single value >1.5 ULN or urine output <0.5ml/kg/h for 6h